Cancer Family
Genitourinary System Neoplasm
CI-CAN-00000018Explore in graph →
Non-malignant3,849 active trials61 approved drugs306 evidence items
- NCIt
- C156482
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000018Explore in graph →
Clinical trials
17,388 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06208319 | Development and Evaluation of an Artificial Intelligence Tool for Colposcopy Assistance(IACOL) | unknown | — | 1,000 | Assistance Publique - Hôpitaux de ParisOTHER | 0 | Feb 1, 2024 | clinicaltrials |
| NCT06236958 | Effect of Early Enteral Nutrition on Postoperative Recovery of Ovarian Cancer Patients | unknown | — | 200 | Luo ChengyanOTHER | 1 | Feb 1, 2024 |
| clinicaltrials |
| NCT05940415 | Conducting Active Surveillance Without Prostate Biopsy for Patients With Low-risk Suspected Prostate Cancer(ASWBP) | unknown | — | 220 | Anhui Provincial HospitalOTHER_GOV | 1 | Jan 31, 2024 | clinicaltrials |
| NCT06234670 | Risk Factors and A Prediction Model of Recurrence of Uterine Fibroids | unknown | — | 3,200 | Wenwen WangOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT06235268 | Prospective and Multicenter Italian Registry of Locally Advanced-Metastatic Urothelial Carcinoma | unknown | — | 1,000 | Federation of Italian Cooperative Oncology GroupsOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT05193656 | Bladder Cancer Detection Using Convolutional Neural Networks(BLAInostic) | unknown | — | 5,000 | Zealand University HospitalOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT05452824 | Participating in Tai Chi to Reduce Anxiety and Keep up Physical Function(PEAK-RP) | unknown | N/A | 40 | AHS Cancer Control AlbertaOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT04470921 | STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands(STOPOVCA) | unknown | — | 10,000 | Radboud University Medical CenterOTHER | 1 | Jan 26, 2024 | clinicaltrials |
| NCT05489926 | A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure | unknown | Phase 2 | 15 | Zhejiang Cancer HospitalOTHER | 1 | Jan 26, 2024 | clinicaltrials |
| NCT04693169 | [Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer Patients | unknown | N/A | 20 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jan 25, 2024 | clinicaltrials |
| NCT04967001 | 68Ga-PSMA PET in the Prostate Cancer | unknown | N/A | 300 | Xijing HospitalOTHER | 1 | Jan 25, 2024 | clinicaltrials |
| NCT05738902 | Adherence and Compliance to ERAS in Gynecological Surgery(ERASGYNBS002) | unknown | — | 600 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 1 | Jan 25, 2024 | clinicaltrials |
| NCT06223308 | A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 54 | Shanghai Huaota Biopharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 25, 2024 | clinicaltrials |
| NCT06223763 | SUROVA - Surgery in Ovarian Cancer, Comparing Primary and Interval Cytoreductive Surgery(SUROVA) | unknown | — | 5,000 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Jan 25, 2024 | clinicaltrials |
| NCT01864096 | The Metformin Active Surveillance Trial (MAST) Study(MAST) | unknown | Phase 3 | 408 | University Health Network, TorontoOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT03432949 | Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPC(TRANCE) | unknown | Phase 4 | 24 | University Health Network, TorontoOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT06221774 | Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors | unknown | Phase 1 / Phase 2 | 42 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT06222008 | Study on Symptom Clusters During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution | unknown | — | 40 | Yandi ZhuOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT06222125 | A Study of HB0025 Injection in Patients With Advanced Renal Cancer | unknown | Phase 2 | 100 | Huabo Biopharm Co., Ltd.INDUSTRY | 1 | Jan 24, 2024 | clinicaltrials |
| NCT06182644 | Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors(FAPI) | unknown | N/A | 30 | Guangdong Provincial People's HospitalOTHER | 1 | Jan 22, 2024 | clinicaltrials |
| NCT05916690 | Electrochemotherapy for the Treatment of Vulvar Cancer | unknown | N/A | 20 | Institute of Oncology LjubljanaOTHER | 1 | Jan 19, 2024 | clinicaltrials |
| NCT05084677 | Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer | unknown | Phase 2 | 96 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT06211023 | A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer | unknown | Phase 2 / Phase 3 | 520 | Suzhou Suncadia Biopharmaceuticals Co., Ltd.INDUSTRY | 0 | Jan 18, 2024 | clinicaltrials |
| NCT05065021 | Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor | unknown | Phase 2 | 40 | University Health Network, TorontoOTHER | 1 | Jan 17, 2024 | clinicaltrials |
| NCT04994197 | Urothelial Tumor Risk Genes Detection With Genetron Uro V1 and LC-WGS | unknown | — | 970 | Ruijin HospitalOTHER | 1 | Jan 10, 2024 | clinicaltrials |
| NCT05584787 | Transperineal Laser Ablation for Low- and Intermediate Risk Prostate Cancer: a Single Cohort Analysis | unknown | N/A | 20 | San Carlo di Nancy HospitalOTHER | 1 | Jan 10, 2024 | clinicaltrials |
| NCT05161728 | PSMA Response in Metastasized Hormone Sensitive Prostate Cancer(PET-MaN) | unknown | N/A | 150 | Roderick van den BerghOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT05539300 | PSMA Response in Metastasized Hormone Sensitive Prostate Cancer - Enzalutamide(PET-MaN-enza) | unknown | N/A | 150 | UMC UtrechtOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT06171581 | Effect of Stress Ball Use on Anxiety Level During Endometrial Biopsy Procedure | unknown | N/A | 70 | Zonguldak Bulent Ecevit UniversityOTHER | 0 | Jan 9, 2024 | clinicaltrials |
| NCT04683549 | HPV Serum Level and FDG PET CT in Patients With Cervical Cancer Treated With Radical Radiochemotherapy(HPV-RICCO) | unknown | N/A | 30 | The Greater Poland Cancer CentreOTHER | 1 | Jan 8, 2024 | clinicaltrials |
| NCT06133699 | Sentinel Lymph Node Biopsy in Stage AI-IIA Germ Cell Tumors(PITERLAND) | unknown | N/A | 44 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT06144099 | Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Non-cardiac Surgery | unknown | Phase 4 | 154 | Konkuk University Medical CenterOTHER | 0 | Jan 2, 2024 | clinicaltrials |
| NCT06182735 | CD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell Carcinoma | unknown | Phase 1 | 9 | Fudan UniversityOTHER | 1 | Dec 27, 2023 | clinicaltrials |
| NCT06182917 | Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients | unknown | — | 35 | West China Second University HospitalOTHER | 1 | Dec 27, 2023 | clinicaltrials |
| NCT02473003 | Physical Training and Cancer-a Multicenter Clinical Trial(Phys-Can) | unknown | N/A | 600 | Uppsala UniversityOTHER | 0 | Dec 21, 2023 | clinicaltrials |
| NCT06178601 | A Study of RC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma | unknown | Phase 2 | 36 | Shanxi Province Cancer HospitalOTHER | 1 | Dec 21, 2023 | clinicaltrials |
| NCT02138721 | Local Treatment With RP for Newly-diagnosed mPCa(LoMP) | unknown | N/A | 80 | University Hospital, GhentOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT06176274 | Pre-Operative Prehabilitation Program Women With Gynecological Cancer | unknown | N/A | 50 | Istanbul University - CerrahpasaOTHER | 1 | Dec 19, 2023 | clinicaltrials |
| NCT02969083 | Feasibility of Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma(URANUS) | unknown | Phase 2 | 200 | The European Uro-Oncology GroupOTHER | 3 | Dec 18, 2023 | clinicaltrials |
| NCT03935256 | Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer | unknown | Phase 2 | 24 | Loyola UniversityOTHER | 1 | Dec 18, 2023 | clinicaltrials |
| NCT05150236 | EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC(ANZUP2001) | unknown | Phase 2 | 93 | Australian and New Zealand Urogenital and Prostate Cancer Trials GroupOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT06029036 | A Phase II Neoadjuvant Study of Darolutamide Plus ADT in Men With Localized Prostate Cancer | unknown | Phase 2 | 53 | Peking University First HospitalOTHER | 1 | Dec 12, 2023 | clinicaltrials |
| NCT03108703 | Assessment of QoL and Outcomes With SBRT for RCC(AQuOS-RCC) | unknown | N/A | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 7, 2023 | clinicaltrials |
| NCT04675320 | Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors(IMMUNOPARP) | unknown | — | 50 | Centre Georges Francois LeclercOTHER | 1 | Dec 7, 2023 | clinicaltrials |
| NCT06161272 | Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi | unknown | Phase 2 | 80 | Guangxi Medical UniversityOTHER | 1 | Dec 7, 2023 | clinicaltrials |
| NCT05063760 | Exercise in Testicular Germ Cell Cancer Survivors(ExCell) | unknown | N/A | 60 | Slovak Academy of SciencesOTHER_GOV | 1 | Dec 5, 2023 | clinicaltrials |
| NCT06154499 | Archive Prostate. Observational Study of Patients Who Underwent Radical Prostatectomy Surgery | unknown | — | 1,784 | IRCCS San RaffaeleOTHER | 1 | Dec 4, 2023 | clinicaltrials |
| NCT06155370 | Construction of Gynecological Tumor Organoids | unknown | — | 200 | Peking Union Medical College HospitalOTHER | 0 | Dec 4, 2023 | clinicaltrials |
| NCT05446324 | Feasibility of Gallium-68-tilmanocept PET/CT for Sentinel Lymph Node Detection in Endometrial Cancer(SENGA) | unknown | Phase 3 | 10 | UMC UtrechtOTHER | 1 | Dec 1, 2023 | clinicaltrials |
| NCT06152666 | Day-case Endourology; Enablers, Barriers, Unexpected Outcomes | unknown | — | 15 | Royal Devon and Exeter NHS Foundation TrustOTHER | 1 | Dec 1, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Feb 1, 2024source: clinicaltrials